All Posts: cancer
-
Raskin Discusses Cancer Diagnosis and Cura Personalis at Annual Kovach Lecture
On September 26, U.S. Rep. Jamie Raskin came to Georgetown to discuss his cancer experiences and thank his treating physician, MedStar Georgetown University Hospital hematologist-oncologist Joseph L. Roswarski, MD, at the third annual Edward M. Kovach Cura Personalis Endowed Lecture.
Category: Lombardi Stories
-
Routine Lung Screening Spots Aggressive Cancer Early, Allows Successful Treatment
The detection of an aggressive form of lung cancer in a patient treated by experts at Georgetown University’s Lombardi Comprehensive Cancer Center demonstrates the importance of routine screenings and a strong relationship between patients and their primary care physicians.
Category: Lombardi Stories
-
Biology Behind New Drug Used to Treat Triple-Negative Breast Cancer Uncovered
How TTP488 (azeliragon), an experimental drug, impairs aggressive, triple-negative breast cancer from metastasizing has been uncovered at the cellular level, according to researchers at Georgetown University’s Lombardi Comprehensive Cancer Center.
Category: News Release
-
Research To Help Patients Make Informed Decisions About Breast MRI
While many people think that breast cancer screening and mammography are synonymous, Claire Conley, PhD, wants people to know that women who are at higher than average risk for breast cancer may also receive a breast MRI.
Category: Lombardi Stories
-
Researchers Develop Method to Monitor Cancer Radiotherapy Effects at the Cellular Level
Using complex molecular tools, researchers have determined how to measure, in real time, the effect that radiation treatment for cancer can have at the cellular level on surrounding healthy tissue.
Category: News Release
-
Novel Research Shows Older Breast Cancer Survivors Experience Accelerated Aging, Worse Functional Outcomes
In a new multicenter study, researchers from Georgetown University’s Lombardi Comprehensive Cancer Center, the Medical College of Wisconsin (MCW), UCLA and several other leading cancer centers from across the nation examined whether cancer and its treatments accelerate aging. Using novel epigenetic measures to assess biological aging, investigators found that older breast cancer survivors — particularly those exposed to chemotherapy — showed greater epigenetic aging than their same-aged peers without cancer, which may relate to worse outcomes.
Category: News Release
-
Determining How a Sugar Molecule Can Affect Cancer Cell Response to Chemoradiotherapy
Researchers at Georgetown University’s Lombardi Comprehensive Cancer Center and colleagues who have been exploring the complexities of biochemical pathways involved in cancer development have found that a form of glucose, a type of sugar, is intricately linked to a pathway used to build DNA molecules. When this pathway is overactive, it can lead to cancer and resistance to chemoradiotherapy.
Category: News Release
-
Veterans Exposed to Agent Orange May Be at Increased Risk of Developing Progressive Blood Cancers
Research conducted at Georgetown University’s Lombardi Comprehensive Cancer Center and the Washington DC VA Medical Center on a database of veterans exposed to Agent Orange found an association for an increased risk of developing myeloproliferative neoplasms (MPNs), which are acquired stem cell disorders that can lead to overproduction of mature blood cells complicated by an increased risk of blood clots in arteries and veins.
Category: News Release
-
Types of Bacteria Vary Widely in Tumors of People with Early vs. Late-Onset Colorectal Cancer
Researchers at Georgetown University’s Lombardi Comprehensive Cancer Center studied the microbiome of people with colorectal cancer and found the makeup of the bacteria, fungi and viruses in a person’s tumor varied significantly depending on whether they were diagnosed with early onset disease (age 45 or younger) or late-onset disease (age 65 or older).
Category: News Release
-
New Study Finds Personalized mRNA Vaccine Given with Immunotherapy Reduces Recurrence in High-Risk Melanoma Patients
A new study conducted by an international team of researchers, including clinical investigators at Georgetown University’s Lombardi Comprehensive Cancer Center, demonstrates that a personalized cancer mRNA vaccine combined with immunotherapy reduces recurrence and improves survival for people with advanced melanoma.
Category: Lombardi Stories